Learn About Histiocytosis

What is the definition of Histiocytosis?

Histiocytosis is a general name for a group of disorders or "syndromes" that involve an abnormal increase in the number of specialized white blood cells that are called histiocytes.

Recently, new knowledge about this family of diseases has led experts to develop a new classification. Five categories have been proposed:

  • L group -- includes Langerhans cell histiocytosis and Erdheim-Chester disease
  • C group -- includes non-Langerhans cell histiocytosis that involves the skin
  • M group -- includes malignant histiocytosis
  • R group -- includes Rosai-Dorfman disease
  • H Group -- includes hemophagocytic lymphohistiocytosis

This article focuses only on the L group, which includes Langerhans cell histiocytosis and Erdheim-Chester disease.

Save information for later
Sign Up
What are the alternative names for Histiocytosis?

Langerhans cell histiocytosis; Erdheim-Chester disease

What are the causes of Histiocytosis?

There has been debate as to whether Langerhans cell histiocytosis and Erdheim-Chester disease are inflammatory, immune disorders, or cancer-like conditions. Recently, through the use of genomics scientists have found that these forms of histiocytosis show gene changes (mutations) in early white blood cells. This leads to abnormal behavior in the cells. The abnormal cells then increase in various parts of body including the bones, skin, lungs, and other areas.

Langerhans cell histiocytosis is a rare disorder that can affect people of all ages. The highest rate is among children ages 5 to 10. Some forms of the disorder are genetic, which means they are inherited.

Erdheim-Chester disease is a rare form of histiocytosis affecting mainly adults that involves multiple parts of the body.

What are the symptoms of Histiocytosis?

Both Langerhans cell histiocytosis and Erdheim-Chester disease can affect the whole body (systemic disorder).

Symptoms can vary between children and adults, but they may have some of the same symptoms. Tumors in weight-bearing bones, such as the legs or spine, may cause the bones to fracture without an obvious reason.

Symptoms in children may include:

  • Abdominal pain
  • Bone pain
  • Delayed puberty
  • Dizziness
  • Ear drainage that continues long-term
  • Eyes that appear to stick out more and more
  • Irritability
  • Failure to thrive
  • Fever
  • Frequent urination
  • Headache
  • Jaundice
  • Limping
  • Mental decline
  • Rash
  • Seborrheic dermatitis of the scalp
  • Seizures
  • Short stature
  • Swollen lymph glands
  • Thirst
  • Vomiting
  • Weight loss

Note: Children over 5 years old often have only bone involvement.

Symptoms in adults may include:

  • Bone pain
  • Chest pain
  • Cough
  • Fever
  • General discomfort, uneasiness, or ill feeling
  • Increased amount of urine
  • Rash
  • Shortness of breath
  • Thirst and increased drinking of fluids
  • Weight loss
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Histiocytosis?

People with Langerhans cell histiocytosis that involves only a single area (such as bone or skin) may be treated with local surgery. However, they will need to be followed closely to look for signs that the disease has spread.

People with widespread Langerhans cell histiocytosis or Erdheim-Chester disease require medicines to reduce symptoms and control the spread of the disease. Recent studies show that nearly all adults with widespread histiocytosis have gene mutations in the tumors, which appear to cause the disorder. Medications that inhibit these gene mutations, such as vemurafenib are currently available. Other similar drugs are also in development.

Langerhans cell histiocytosis and Erdheim-Chester disease are very rare disorders. Therefore there is limited information about the best course of treatment. People with these conditions may want to take part in ongoing clinical trials designed to identify new treatments.

Other medicines or treatments may be used, depending on the outlook (prognosis) and response to the starting medicines. Such treatments may include:

  • Interferon alpha
  • Cyclophosphamide or vinblastine
  • Etoposide
  • Methotrexate
  • Vemurafenib, if the BRAF V600E mutation is found
  • Stem cell transplantation

Other treatments may include:

  • Antibiotics to fight infections
  • Breathing support (with a breathing machine)
  • Hormone replacement therapy
  • Physical therapy
  • Special shampoos for scalp problems
  • Supportive care (also called comfort care) to relieve symptoms

In addition, people with these conditions who smoke are encouraged to stop since smoking may worsen the response to treatment.

Who are the top Histiocytosis Local Doctors?
Learn about our expert tiers
Learn more
What are the support groups for Histiocytosis?

Histiocytosis Association -- histio.org

What is the outlook (prognosis) for Histiocytosis?

Langerhans cell histiocytosis and Erdheim-Chester disease can affect many organs and can lead to death.

About one half of those with pulmonary histiocytosis improve, while others have permanent loss of lung function over time.

In very young people, the outlook depends on the specific histiocytosis and how severe it is. Some children can live a normal life with minimal disease involvement, while others do poorly. Young children, especially infants, are more likely to have body-wide symptoms that lead to death.

What are the possible complications of Histiocytosis?

Complications may include:

  • Diffuse interstitial pulmonary fibrosis (deep lung tissues that become inflamed and then damaged)
  • Spontaneous collapsed lung

Children may also develop:

  • Anemia caused by spreading of the tumors to the bone marrow
  • Diabetes insipidus
  • Lung problems that lead to lung failure
  • Problems with the pituitary gland that lead to growth failure
When should I contact a medical professional for Histiocytosis?

Call your health care provider if you or your child has symptoms of this disorder. Go to the emergency room if shortness of breath or chest pain develops.

How do I prevent Histiocytosis?

Avoid smoking. Quitting smoking can improve the outcome in people with Langerhans cell histiocytosis that affects the lungs.

There is no known prevention of this disease.

Eosinophilic granuloma - X-ray of the skull
Respiratory system
What are the latest Histiocytosis Clinical Trials?
Phase 2 Study of DAY101 in Relapsed and Refractory Langerhans Cell Histiocytosis

Summary: This phase II trial tests the safety, side effects and best dose of DAY101 in treating patients with Langerhans cell histiocytosis that are growing, spreading, or getting worse (progressive), has come back (relapsed), or does respond to treatment (refractory). DAY101 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and blocks over-active growth pathways in...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)

Summary: Hemophagocytic lymphohistiocytosis in adults (HLH) is at 68% mortality whereas 78% of all cases remain undiagnosed though therapies are available which clearly reduce mortality. The investigators aim to systematically investigate this life-threatening hyperinflammatory syndrome in intensive care units (ICU) in order to detect biomarkers that are highly sensitive and highly specific for HLH in ICU ...

What are the Latest Advances for Histiocytosis?
Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.
Current perspectives on the role of liver transplantation for Langerhans cell histiocytosis: A narrative review.
Tired of the same old research?
Check Latest Advances
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study.
Who are the sources who wrote this article ?

Published Date: May 31, 2020
Published By: Diane M. Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Goyal G, Young JR, Koster MJ, et al. The Mayo Clinic Histiocytosis Working Group consensus statement for the  diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Mayo Clin Proc. 2019;94(10):2054-2071. PMID: 31472931 pubmed.ncbi.nlm.nih.gov/31472931/.

Rollins BJ, Berliner N. Histiocytoses. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 160.